Drug Type Radiolabeled antibody, Therapeutic radiopharmaceuticals |
Synonyms Anti-ferritin antibody-Y90, Radiolabelled anti-isoferritin antibody + [1] |
Target |
Mechanism Ferritin inhibitors(Ferritin inhibitors), Ionising radiation emitters |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hodgkin's Lymphoma | Phase 2 | US | - | |
Non-Small Cell Lung Cancer | Phase 2 | - | - | |
Pancreatic Cancer | Phase 2 | - | - |